Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows
By
Andrew Gregory
Crisped on the outside, thoughtful enough on the inside.
Summary
A clinical trial has shown that a daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, one of the deadliest and hardest-to-treat cancers. Experts at the world's largest cancer conference have hailed the drug as a 'gamechanger' and one of the biggest breakthroughs in decades. Pancreatic cancer is often diagnosed late, with more than half of patients only discovering it after it has spread, and current treatment options are extremely limited.
Key quotes
· 3 pulledA daily pill can double survival time in patients with the world's deadliest cancer, according to the results of a clinical trial that experts are saying is a 'gamechanger'
For decades, scientists have worked relentlessly trying to find clever solutions for a form of cancer that is often found late.
More than half of patients are only diagnosed after it has spread.
You might also wanna read
Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial
A new experimental pill called daraxonrasib has shown promising results in extending survival for patients with advanced pancreatic cancer.
cnbc.com·2h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer patients
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·3h ago